Further analysis of these lncRNAs with techniques such as CLIP sequencing (where the RNA-protein complex is cross-linked and then immunoprecipitated, followed by RNA-Seq) are needed to explore whether the lncRNAs identified here may modulate gene expression and CAD risk through CTCF binding. The gene discussed is CTCF; the disease is coronary artery disorder.